Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/b1b20057-f166-4065-8a3d-1d880d9ca52f/

AIRS

Airsculpt Technologies Inc
Chart
$5.11
Latest Week 2026-06-05
HealthcareMedical Care FacilitiesSMALL
Snapshot 2026-06-07 · 0.0w · Fresh
0.04
OS Score
20.0%
Value
14.0%
Quality
19.0%
Momentum
3/9
F-Score
0.167
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
20.0%ile
P/S
2.3×
P/B
3.5×
FCF Yield
0.021
EBITDA/EV
0.013
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
90.00000000
/100 — 1=cheapest
VC2 (Trending Value)
90.00000000
/100
VC3 (Buyback)
90.00000000
/100
VC2 score of 90.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
14.0%ile
ROE
-0.112
ROA
-0.058
Net Margin
-0.074
Op Margin
-0.049
GPA
0.479
D/E
0.91
Current
0.75
F-Score
3/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
-0.118
Stability
0.942
lower=better
Accruals
-0.097
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
19.0%ile
6M Return
68.1%
12M Return
0.8%
12-1 Mom
-23.9%
Risk-Adj
-0.20
Vol 252d
117.3%
Vol 60d
291.6%
↑ Expanding
Max DD 12M
-86.1%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -24% signals a downtrend — price is moving against you. Near-term vol (292%) is expanding vs long-term (117%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.04
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
6.0%
Sector Quality %ile
4.2%
P/B z-score
-0.12
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Volatility Expanding
60-day vol (292%) significantly exceeds 252-day (117%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
38.5% avg (5 factors)
Quality
D
35.3% avg (8 factors)
Momentum
D
38.9% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.040—1—
Value %ile0.200—1—
Quality %ile0.140—1—
Momentum %ile0.190—1—
F-Score3.000—1—
Confidence0.879—1—
Volatility1.173—1—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
2.34
Price / Book
3.54
Price / Cash Flow
47.33
FCF Yield
2.1%
EBITDA / EV
1.3%
Sales Yield (1/P·S)
0.3891
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-11.2%
Return on Assets
-5.8%
Net Margin
-7.4%
Operating Margin
-4.9%
Gross Profit / Assets
Novy-Marx GPA
47.9%
Debt / Equity
0.91
Current Ratio
0.75
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.097
MomentumPrice trend strength over different horizons
6M Return
68.1%
12M Return
0.8%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-23.9%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.20
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-11.8%
Earnings Stability (CV)
Lower = more stable
0.942
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
3
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
90
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
90
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
90
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity